AI Portfolio Summary
In 2026 Q1, Medicxi Ventures Management (Jersey) Ltd maintained a portfolio of 5 distinct positions. Conversely, Medicxi Ventures Management (Jersey) Ltd completely exited their position in RAPT THERAPEUTICS IN.
Total Positions
5
Quarter
2026 Q1
Top Holding
CNTA (80.8%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-5 of 5
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CNTA
CENTESSA PHARMA...
|
Healthcare | 80.76% | 59.80% |
#1
Prev: #1
|
7.0 | no change | no change |
P
S
|
19,963,157 | $792,936,596 | 2021 Q2 | 13F Filing | 2026-03-31 | 2026-04-21 | |||
|
NAMS
NEWAMSTERDAM PH...
|
Healthcare | 8.72% | 12.06% |
#2
1
Prev: #3
|
5.5 | -195,383 | -6.8% |
P
S
|
2,674,182 | $85,600,566 | 2022 Q4 | 13F Filing | 2026-03-31 | 2026-04-21 | |||
|
PHAT
PHATHOM PHARMAC...
|
Healthcare | 8.45% | 14.83% |
#3
1
Prev: #2
|
5.4 | no change | no change |
P
S
|
7,464,572 | $82,931,395 | 2019 Q4 | 13F Filing | 2026-03-31 | 2026-04-21 | |||
|
AURA
AURA BIOSCIENCE...
|
Healthcare | 2.07% | 1.98% |
#4
1
Prev: #5
|
2.3 | no change | no change |
P
S
|
3,039,892 | $20,336,877 | 2021 Q4 | 13F Filing | 2026-03-31 | 2026-04-21 | |||
|
RAPT
RAPT THERAPEUTI...
|
Healthcare | 0.00% | 11.33% |
Sold All 😨
(Was: #4) |
0.0 | -2,794,000 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-04-21 |
Showing 1-5 of 5 holdings